The NFL Combine is officially here! More than 300 players from schools all across the country will descend upon Indianapolis with the hope that they can improve their draft stock. And while the prospects are the main attraction,
The fast-casual Mediterranean chain hopes to open locations in Detroit, Miami, Pittsburgh, and Indianapolis, CEO Brett Schulman said Tuesday. Cava hopes to expand its physical footprint after a year of financial success,
Miami linebacker Francisco Mauigoa runs the 40-yard dash at the NFL football scouting combine in Indianapolis, Thursday, Jan. 27, 2025. (AP Photo/)
Ten Miami Hurricanes stars will be part of more than 300 NFL draft prospects taking part in this weekend's NFL Scouting Combine. Indianapolis becomes the center of the football world this weekend as host of the NFL combine,
Miami star wide receiver Tyreek Hill recently had ligament surgery on his left wrist and is expected to be ready for training camp, Dolphins coach Mike McDaniel said Tuesday at the NFL Scouting Combine in Indianapolis.
The Colorado star is widely considered a top two quarterback in the 2025 NFL Draft class with Miami’s Cam Ward.
Friday at the 2025 NFL Combine in Indianapolis was quarterback day. All of the quarterbacks spoke to the media on Friday including Miami’s Cam Ward and Colorado’s Shedeur Sanders, the consensus two best QBs available.
3don MSN
Miami Dolphins coach Mike McDaniel says wide receiver Tyreek Hill recently had surgery to repair ligament damage in his wrist but is expected to be available for training camp.
The Miami Dolphins are operating this off-season as if star offensive tackle Terron Armstead will retire, coach Mike McDaniel told reporters Tuesday at the NFL scouting combine.
INDIANAPOLIS — The Miami Dolphins still don't know whether five-time Pro Bowl tackle Terron Armstead wants to play a 13th NFL season, but head coach Mike McDaniel indicated the team is ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) announces that the Biogenix Molecular Research Center in Miami, FL, is recruiting and dosing patients in the ProstACT Global Phase 3 trial1 of TLX591 for patients with advanced prostate cancer,
Some results have been hidden because they may be inaccessible to you
Show inaccessible results